Leef Brands (LEEEF) EBITDA (2025 - 2026)

Leef Brands' (LEEEF) quarterly EBITDA came in at -$426253.0 in Q1 2026, down 260.38% year-on-year from $265776.0 in Q1 2025, and down 260.38% quarter-over-quarter from $265776.0 in Q1 2025.

Leef Brands (LEEEF) EBITDA (2025 - 2026) Analysis & Trends

Leef Brands has disclosed EBITDA across 2 years of filings, most recently posting -$426253.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 652.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 833.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 325.80 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -681,231.97
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 185.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 307.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -67.29 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 81.33 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -98.81 Mn
10 Leef Brands - - 4.62 Mn -426,253.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -426,253.00
Mar 31, 2025 265,776.00